• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体神经内分泌肿瘤中的滤泡细胞。

Follicular cells in pituitary neuroendocrine tumors.

作者信息

Delfin Luvy, Mete Ozgur, Asa Sylvia L

机构信息

Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.

Department of Pathology, University Health Network, University of Toronto, Toronto, M5G 2C4, Canada.

出版信息

Hum Pathol. 2021 Aug;114:1-8. doi: 10.1016/j.humpath.2021.05.002. Epub 2021 May 12.

DOI:10.1016/j.humpath.2021.05.002
PMID:33991528
Abstract

Follicular cells (FCs) are thought to be agranular, non-hormone-producing stellate cells distributed throughout the adenohypophysis, occasionally arranged around colloid-filled follicles, and thought to be more prominent in the vicinity of necrosis and apoptotic cells. A distinct but similar cell type, the folliculostellate cell (FSC), is a sustentacular cell that is negative for keratins and stains for S100, GFAP, and SOX10. While several studies have examined FSCs in pituitary neuroendocrine tumors (PitNETs), the distribution and derivation of FCs in these lesions is unclear. We examined the presence and distribution of FCs in 104 PitNETs obtained by trans-sphenoidal surgery, using immunohistochemistry for keratins as well as the full complement of immunohistochemical stains for tumor characterization. The tumors included 9 somatotroph, 5 mammosomatotroph, 7 lactotroph, 7 immature PIT1-lineage, 2 acidophil stem cell, 17 corticotroph, 53 gonadotroph, 2 null cell, and 2 unusual plurihormonal tumors. CK-positive FCs were only identified in gonadotroph PitNETs and were found in 12 (23%) of those tumors; all other tumor types were negative for FCs. FCs express keratins identified by CAM5.2, AE1/AE3, CK18, and CK19 antibodies. FCs were identified scattered singly among hormone-producing neuroendocrine cells, in small clusters of 3-5 cells and surrounding colloid-filled follicles, as well as linearly along intratumoral blood vessels. Sequential stains showed that FCs express nuclear SF1 and GATA3, transcription factors of gonadotrophs, and multiplex immunohistochemistry confirmed colocalization of SF1 in the nucleus of keratin-positive FCs. In this series, FCs were exclusively found in gonadotroph PitNETs and occurred in 23% of those tumors. Co-expression of gonadotroph transcription factors in FCs supports the concept of cellular plasticity and transformation of neoplastic hormone-producing neuroendocrine cells to FCs. Further studies are required to determine if and why gonadotrophs alone undergo this transformation, the function of these cells and whether they have prognostic value.

摘要

滤泡细胞(FCs)被认为是无颗粒、不产生激素的星状细胞,分布于整个腺垂体,偶尔围绕充满胶体的滤泡排列,并且在坏死和凋亡细胞附近更为突出。一种独特但相似的细胞类型,即滤泡星状细胞(FSC),是一种支持细胞,对角蛋白呈阴性,对S100、GFAP和SOX10呈阳性染色。虽然有几项研究检测了垂体神经内分泌肿瘤(PitNETs)中的FSCs,但这些病变中FCs的分布和来源尚不清楚。我们使用角蛋白免疫组织化学以及用于肿瘤特征描述的全套免疫组织化学染色,检测了经蝶窦手术获得的104例PitNETs中FCs的存在和分布。这些肿瘤包括9例生长激素细胞、5例泌乳生长激素细胞、7例催乳素细胞、7例未成熟PIT1谱系、2例嗜酸性干细胞、17例促肾上腺皮质激素细胞、53例促性腺激素细胞、2例无功能细胞和2例不寻常的多激素肿瘤。CK阳性的FCs仅在促性腺激素细胞PitNETs中被鉴定出来,在其中12例(23%)肿瘤中发现;所有其他肿瘤类型的FCs均为阴性。FCs表达由CAM5.2、AE1/AE3、CK18和CK19抗体鉴定的角蛋白。FCs被鉴定为单个散在于产生激素的神经内分泌细胞之间、3 - 5个细胞的小簇中以及围绕充满胶体的滤泡,并且沿肿瘤内血管呈线性分布。连续染色显示FCs表达促性腺激素细胞的核转录因子SF1和GATA3,多重免疫组织化学证实SF1在角蛋白阳性FCs的细胞核中共定位。在本系列中,FCs仅在促性腺激素细胞PitNETs中发现,且在其中23%的肿瘤中出现。FCs中促性腺激素细胞转录因子的共表达支持了细胞可塑性以及肿瘤性产生激素的神经内分泌细胞向FCs转化的概念。需要进一步研究来确定是否以及为何只有促性腺激素细胞会发生这种转化、这些细胞的功能以及它们是否具有预后价值。

相似文献

1
Follicular cells in pituitary neuroendocrine tumors.垂体神经内分泌肿瘤中的滤泡细胞。
Hum Pathol. 2021 Aug;114:1-8. doi: 10.1016/j.humpath.2021.05.002. Epub 2021 May 12.
2
Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.同步发生的不同细胞谱系的垂体神经内分泌肿瘤。
Endocr Pathol. 2018 Dec;29(4):332-338. doi: 10.1007/s12022-018-9545-4.
3
Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.表达 PIT1 和 SF1 的多谱系垂体神经内分泌肿瘤(PitNETs)。
Endocr Pathol. 2023 Sep;34(3):273-278. doi: 10.1007/s12022-023-09777-x. Epub 2023 Jun 2.
4
GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors.GATA3 免疫反应扩大了垂体神经内分泌肿瘤的转录因子谱。
Mod Pathol. 2019 Apr;32(4):484-489. doi: 10.1038/s41379-018-0167-7. Epub 2018 Nov 2.
5
Cytokeratin profiles in pituitary neuroendocrine tumors.垂体神经内分泌肿瘤中的细胞角蛋白谱。
Hum Pathol. 2021 Jan;107:87-95. doi: 10.1016/j.humpath.2020.10.004. Epub 2020 Oct 21.
6
Overview of the 2022 WHO Classification of Pituitary Tumors.《2022 年世卫组织垂体肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):6-26. doi: 10.1007/s12022-022-09703-7. Epub 2022 Mar 15.
7
[New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].[2022年世界卫生组织版垂体神经内分泌肿瘤的新病理分类及临床意义]
Zhonghua Yi Xue Za Zhi. 2022 Dec 20;102(47):3723-3726. doi: 10.3760/cma.j.cn112137-20220417-00825.
8
Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.垂体瘤的免疫景观揭示了巨噬细胞与促性腺细胞瘤侵袭之间的关联。
J Clin Endocrinol Metab. 2020 Nov 1;105(11). doi: 10.1210/clinem/dgaa520.
9
Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs.对之前被诊断为无功能胰岛细胞瘤的 6 例病例进行免疫组化和超微结构复查。
Brain Tumor Pathol. 2023 Jul;40(3):158-162. doi: 10.1007/s10014-023-00462-9. Epub 2023 Apr 18.
10
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.具有PIT1/SF1共表达的垂体神经内分泌肿瘤表现出独特的临床病理和分子特征。
Acta Neuropathol. 2024 Jan 16;147(1):16. doi: 10.1007/s00401-024-02686-1.

引用本文的文献

1
Factors Influencing Hormone Remission in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors With Residual Tumor: A Retrospective Cohort Study.影响伴有残留肿瘤的生长激素分泌型垂体神经内分泌肿瘤激素缓解的因素:一项回顾性队列研究
CNS Neurosci Ther. 2025 Aug;31(8):e70574. doi: 10.1111/cns.70574.
2
An Old New Friend: Folliculo-Stellate Cells in Pituitary Neuroendocrine Tumors.一位旧相识新朋友:垂体神经内分泌肿瘤中的滤泡星状细胞
Cells. 2025 Jul 3;14(13):1019. doi: 10.3390/cells14131019.
3
A Nexus of Biomolecular Complexities in Pituitary Neuroendocrine Tumors: Insights into Key Molecular Drivers.
垂体神经内分泌肿瘤中生物分子复杂性的关联:对关键分子驱动因素的见解
Biomedicines. 2025 Apr 16;13(4):968. doi: 10.3390/biomedicines13040968.
4
Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours.无功能垂体神经内分泌肿瘤中的干细胞相关转录因子
Free Neuropathol. 2024 Jun 6;5. doi: 10.17879/freeneuropathology-2024-5396. eCollection 2024 Jan.
5
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2.无明显谱系分化的垂体肿瘤表达干细胞标志物 SOX2。
Pituitary. 2024 Jun;27(3):248-258. doi: 10.1007/s11102-024-01385-0. Epub 2024 Mar 14.
6
Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy.肿瘤微环境在垂体神经内分泌肿瘤中的作用:分类、诊断和治疗的新方法
Cancers (Basel). 2023 Nov 6;15(21):5301. doi: 10.3390/cancers15215301.
7
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.第五版世界卫生组织头颈部肿瘤分类更新:2022 年世界卫生组织头颈部神经内分泌肿瘤分类概述。
Head Neck Pathol. 2022 Mar;16(1):123-142. doi: 10.1007/s12105-022-01435-8. Epub 2022 Mar 21.
8
Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours.肿瘤内 S100B+卵泡星状细胞的空间分布与促性腺激素肿瘤中 FSH 和 ERα 的增殖和表达有关。
Acta Neuropathol Commun. 2022 Feb 9;10(1):18. doi: 10.1186/s40478-022-01321-y.